Literature DB >> 19484872

End-stage renal disease in Indonesia: treatment development.

Wiguno Prodjosudjadi1, A Suhardjono.   

Abstract

The number of cases of chronic kidney disease is growing rapidly, especially in the developing world. At a certain level of renal function, progression of chronic kidney disease to endstage renal disease (ESRD) is inevitable. ESRD has become a major health problem because it is a devastating medical condition, and the cost of treatment is a huge economic burden. This article presents data collected from 13 nephrology centers in response to specifically designed questionnaires. These centers were divided into 7 groups on the basis of geographic location. Previous data had given the impression that the incidence and prevalence of ESRD had increased, and the results of this study support these previous data. Since a national registry of ESRD has just been developed for Indonesia and we can present only limited data in this study, the numbers in this article underestimate the true incidence and prevalence rates. Although hemodialysis facilities have been developed rapidly, further development is still required. Continuous ambulatory peritoneal dialysis as an alternative renal replacement therapy (RRT) is only now being introduced. Kidney transplantation programs expand very slowly. RRT still imposes a high cost of treatment for ESRD; therefore, these treatments are unaffordable for most patients. Recently, government health insurance has covered financially strained families requiring RRT. Since the cost of RRT for ESRD has significantly increased over time, the management approach should be shifted from treatment to prevention.

Entities:  

Mesh:

Year:  2009        PMID: 19484872

Source DB:  PubMed          Journal:  Ethn Dis        ISSN: 1049-510X            Impact factor:   1.847


  11 in total

1.  Economic evaluation of end stage renal disease patients undergoing hemodialysis.

Authors:  A Suja; R Anju; V Anju; J Neethu; P Peeyush; R Saraswathy
Journal:  J Pharm Bioallied Sci       Date:  2012-04

2.  Management and outcome of children with end-stage renal disease in northwest Iran.

Authors:  F Mortazavi; M Maleki
Journal:  Indian J Nephrol       Date:  2012-03

Review 3.  Challenges in diabetes management in Indonesia: a literature review.

Authors:  Pradana Soewondo; Alessandra Ferrario; Dicky Levenus Tahapary
Journal:  Global Health       Date:  2013-12-03       Impact factor: 4.185

Review 4.  How to meet the demand for good quality renal dialysis as part of universal health coverage in resource-limited settings?

Authors:  Yot Teerawattananon; Alia Luz; Songyot Pilasant; Suteenoot Tangsathitkulchai; Sarocha Chootipongchaivat; Nattha Tritasavit; Inthira Yamabhai; Sripen Tantivess
Journal:  Health Res Policy Syst       Date:  2016-03-18

Review 5.  A Comprehensive Analysis of the Current Status and Unmet Needs in Kidney Transplantation in Southeast Asia.

Authors:  Chitranon Chan-On; Minnie M Sarwal
Journal:  Front Med (Lausanne)       Date:  2017-06-23

6.  Identifying Factors That Influence Physicians' Recommendations for Dialysis and Conservative Management in Indonesia.

Authors:  Eric A Finkelstein; Semra Ozdemir; Chetna Malhotra; Tazeen H Jafar; Hui Lin Choong; Johnny Suhardjono
Journal:  Kidney Int Rep       Date:  2016-12-13

7.  To include or not include: renal dialysis policy in the era of universal health coverage.

Authors:  Yot Teerawattananon; Saudamini Vishwanath Dabak; Levina Chandra Khoe; Diana Beatriz S Bayani; Wanrudee Isaranuwatchai
Journal:  BMJ       Date:  2020-01-28

8.  Kidney transplantation in Indonesia: An update.

Authors:  Tommy Supit; Eriawan Agung Nugroho; Ardy Santosa; Moh Adi Soedarso; Nanda Daniswara; Sofyan Rais Addin
Journal:  Asian J Urol       Date:  2019-02-22

9.  Hemodialysis in an underserved area (Hama, Syria): A base for a situation analysis project.

Authors:  Ziad Arabi
Journal:  Avicenna J Med       Date:  2012-04

10.  Dispelling the myths of providing dialysis in low- and middle-income countries.

Authors:  Yot Teerawattananon; Kriang Tungsanga; Solange Hakiba; Saudamini Dabak
Journal:  Nat Rev Nephrol       Date:  2021-01       Impact factor: 28.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.